An analysis of the pediatric casualties undergoing massive transfusion in Iraq and Afghanistan

Steven G Schauer1, Abigail R Wheeler2, Michael D April3

  • 1US Army Institute of Surgical Research, JBSA Fort Sam Houston, TX, USA; 59th Medical Wing, JBSA Lackland, TX, USA; Brooke Army Medical Center, JBSA Fort Sam Houston, TX, USA.

Insights

Pediatric trauma patients receiving massive transfusions in combat zones were more severely injured and had lower survival rates. These findings highlight critical differences in pediatric trauma resuscitation during warfare.

Area of Science:

  • Trauma Resuscitation
  • Pediatric Critical Care
  • Military Medicine

Background:

  • Limited data exists on pediatric massive transfusion during trauma resuscitation.
  • This study examines pediatric casualties receiving massive transfusions in US military facilities during combat operations.

Purpose of the Study:

  • To characterize pediatric casualties undergoing massive transfusion in combat settings.
  • To compare their injury patterns and outcomes with non-massive transfusion pediatric trauma patients.

Main Methods:

  • Data from the Department of Defense Trauma Registry (DODTR) from 2007-2016 was analyzed.
  • Pediatric subjects (0-17 years) were stratified by age.
  • Massive transfusion was defined as ≥40 mL/kg of blood products.

Main Results:

  • 15.7% of 3439 pediatric casualties received massive transfusions.
  • Massively transfused children were younger (median 9 years), predominantly male, and injured by explosives in Afghanistan.
  • They had higher injury severity, tachycardia, hypotension, and lower survival rates (82.6%) compared to other pediatric trauma patients.

Conclusions:

  • Pediatric casualties requiring massive transfusion in combat settings exhibit distinct characteristics and poorer outcomes.
  • Further research is needed to translate combat trauma lessons to civilian pediatric care.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
257